Revelation Biosciences, Inc. (REVB) Q3 2024 Earnings
REVB·Reported November 8, 2024·Before market open
Diluted EPS came in at $-40.32, beat the $-136.33 consensus by $96.01.
Diluted EPS
$-40.32beat by $96.01
Consensus: $-136.33
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Revelation Biosciences, Inc.'s Q3 2024 earnings report.
Revelation Biosciences, Inc. (REVB) reported Q3 2024 earnings on November 8, 2024 before market open.
Revelation Biosciences, Inc. reported diluted EPS of $-40.32 for Q3 2024.
EPS beat the consensus estimate of $-136.33 by $96.01.
You can read the 10-Q periodic report (0000950170-24-124036) directly on SEC EDGAR. The filing index links above go to sec.gov.